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Available online xxxxObjectives: Severe lower respiratory tract infection caused by adenovirus is well described in immunocompro-
mised hosts and can cause signiﬁcant morbidity and mortality. We compare and contrast the clinical presenta-
tion, radiological, and virological features of two rare cases in immunocompetent adults admitted to an
intensive care unit in a large, teaching hospital in North West England. We then provide a concise, comprehen-
sive literature review.
Methods: Theﬁrst casewas a 35-year old female asthmaticwhopresentedwith respiratory distress and pneumo-
nitis during peak inﬂuenza season, and recovered after a prolonged hospital stay. The second case was a 73-year
old male who presented with diarrhoea, vomiting, and general malaise outside of inﬂuenza season, developed
respiratory compromise, and died. Adenovirus type 7was identiﬁed in bronchoalveolar lavages and plasma sam-
ples of both patients, each of whom received cidofovir. No other infectious aetiology was identiﬁed.
Results: Clinical and radiological features of severe lower respiratory tract adenoviral infection are similar to other
infectious causes of pneumonia and ARDS, including severe inﬂuenza. This can create diagnostic uncertainty, es-
pecially during inﬂuenza season. Positive adenovirus polymerase chain reaction results can support a diagnosis of
severe lower respiratory tract adenovirus infection in patients with a clinically compatible syndrome and no
other identiﬁed aetiology, with higher viral loads being associated with worse prognosis. Although treatment
is predominantly supportive, early use of cidofovir may improve outcomes.
Conclusions: These rare cases highlight that severe lower respiratory tract adenoviral infection should be consid-
ered in the differential diagnoses of immunocompetent patients presenting with pneumonia and ARDS.
© 2019 TheAuthors. Published by Elsevier Ltd onbehalf of British InfectionAssociation. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Keywords:
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Severe lower respiratory tract infection (sLRTI) due to adenovirus is
well described in immunocompromised hosts. Adenovirus sLRTI is rare
in immunocompetent hosts, especially adults, and evidence regarding
symptoms, diagnosis and management in such instances remains lim-
ited. Here, we describe two cases of severe adenovirus in immunocom-
petent adults admitted to an intensive care unit in a large, teaching
hospital in North West England.
Case 1
In January 2018, a 35-year-old homeless female commercial sex
worker presented with a 4-day history of pharyngitis, myalgia, cough
productive of green sputum, and dyspnoea. She was asthmatic but
took no regular medications and denied related hospital admissions.
Other medical history included obesity, schizophrenia, personality dis-
order, depression and self-harm. Shewas a smoker, did not take alcohol
or drugs and had no ﬁxed abode.
Initial evaluation revealed widespread bilateral rhonchi and severe
respiratory distress. A diagnosis of a life-threatening asthma exacerba-
tion precipitated by LRTI was made. Antimicrobial treatment com-
menced included oseltamivir (due to presentation during peak of
inﬂuenza season and risk factors for viral pneumonitis including chronic
lung disease and obesity), benzylpenicillin and clarithromycin. Respira-
tory distress was treated with oxygen therapy, nebulised bronchodila-
tors, intravenous steroids and magnesium. Investigations showed
lymphopenia with raised inﬂammatory markers but normal liver and
kidney function. Arterial blood gas showed type 1 respiratory failure.
Chest radiograph showed bilateral patchy consolidation. Blood-borne
virus (BBV) screen, including HIV, was negative.
She deteriorated over 48 h with increasing drowsiness and respira-
tory distress. Chest radiograph showed increasing bilateral consolida-
tion (Fig. 1) and antibiotics were broadened to piperacillin/
tazobactam. On day 3, she was transferred to the High Dependency
Unit (HDU, Level-2 Care) for respiratory support. Aminophylline and
salbutamol infusions and CPAP were instigated but she deteriorated
andwas transferred to the intensive care unit (ICU, Level-3 Care) for in-
tubation and ventilation.
Following intubation, bronchoscopy with diagnostic bronchoalveo-
lar lavage (BAL) was performed. Despite paralysis and airway pressure
release ventilation for respiratory recruitment, the patient continued
to desaturate and developed type 2 respiratory failure. In an attempt
to improve ventilation, inhaled nitric oxidewas commenced and the pa-
tient turned into the prone position. On day 8, BAL returned a strongly
positive adenovirus by polymerase chain reaction (PCR) test (Table 1)
and twice weekly cidofovir (with a loading dose one week after the ini-
tial dose) was commenced. Renal replacement therapy was started on
day 12 for renal failure and ﬂuid removal. By day 20, the patient had im-
proved enough to allow tracheostomy to facilitate respiratory weaning
and cessation of sedation.On day 52, the patient no longer required ven-
tilation and, by day 65, she was stepped down to ward-level care.
Case 2
In April 2018, a 73-year-old male presented with a 3-day history of
diarrhoea, vomiting, malaise, myalgia and lethargy without respiratory
symptoms. He was a non-smoker who had amlodipine-controlled hy-
pertension and nephrolithiasis but was normally well and regularly
hill-walked, including an extended 3-day hike just prior to admission.
Examination was unremarkable apart from hypotension (92/
70 mmHg) and pyrexia (38.2 °C). He was lymphopenic but had normal
liver and renal function. A chest radiograph demonstrated left middle-
zone consolidation. Hewas diagnosed with community-acquired pneu-
monia and benzylpenicillin and clarithromycin were started.Please cite this article as: T. Wingﬁeld, L. Dearden, P. Calvert, et al., Ad
immunocompetent adults: a comp..., Clinical Infection in Practice, https://By day 2, he had deteriorated with type 1 respiratory failure.
Benzylpenicillin was switched to piperacillin/tazobactam and he was
transferred to HDU. By day 4, therewas no improvement and antibiotics
were empirically changed to meropenem, doxycycline and linezolid. By
day 6, he required transfer to ICU for intubation and ventilation. A chest
CT demonstrated left-sided consolidation with bilateral pleural effu-
sions (Fig. 1) and he underwent bronchoscopy with BAL. On day 8,
throat swab, BAL and EDTA plasma adenovirus PCRs were strong posi-
tives (Table 1) and a single dose of cidofovir was given. No other bacte-
rial or viral pathogenswere isolated and BBV screen, including HIV, was
negative.
By day 10, his respiratory compromise worsened and hewas turned
into the prone position. He became increasingly haemodynamically un-
stable and developed multi-organ failure including deteriorating renal
function requiring continuous haemoﬁltration. A dose of normal
human immunoglobulinwas given. On day 12, life sustaining treatment
was withdrawn.
Discussion
Human adenoviruses are non-enveloped DNA viruses1 of the
Adenoviridae family grouped into 7 species (A to G) consisting of over
85 known genotypes. They are associated with infections of the con-
junctiva, respiratory and gastrointestinal epithelial tissues, and less
commonly with haemorrhagic cystitis, haemorrhagic colitis, hepatitis,
pancreatitis, nephritis, or encephalitis.2 sLRTI and disseminated disease
are well recognised in immunocompromised patients3 but uncommon
in immunocompetent hosts, especially immunocompetent adults.2 A
multicentre study of 800 immunocompetent adult and child patients
with viral LRTIs identiﬁed adenovirus as the cause in only 2%.4
The clinical and radiological features of adenovirus sLRTI are similar
to sLRTI of other infectious aetiology, which can lead to diagnostic un-
certainty. In reported outbreaks in immunocompetent people,2,5–7 sim-
ilar to recent inﬂuenza epidemics, fever, cough, and myalgia were the
most common symptoms, followed by upper respiratory tract
(rhinorrhoea and nasal congestion)6 and gastrointestinal (diarrhoea
and nausea) symptoms. Predominant ﬁndings on clinical examination
are also not discriminatory and include fever, chest signs (e.g. crepita-
tions), and hypoxia.7 Rarely, patients can develop acute respiratory dis-
tress syndrome (ARDS).8 With regard to diagnosis, standard blood tests
are often unremarkable but liver function tests may be abnormal and
total leucocyte count can be decreased initially9–11; one review of 21
immunocompetent patients with adenovirus pneumonia found lym-
phopenia in 11 (52%) and raised transaminases in 6 (29%).7 Similarly,
reviews including the radiological features of adenovirus-related lung
infection and ARDS have found that the majority of patients had multi-
focal, diffuse, bilateral parenchymal inﬁltrates including ground-glass
on CT while approximately one quarter had lobar consolidation.7,11
With regard to our patients, Case 1 presented during England's inﬂu-
enza season with respiratory symptoms and signs of pneumonitis
followed by bilateral consolidation; Case 2 presented with generalised
and gastrointestinal symptoms following inﬂuenza season and was
found to have unilateral pneumonia and pleural effusions (Fig. 1). Ulti-
mately, from reﬂection on these cases and review of the literature, there
appear to be no clinical features speciﬁc to adenovirus sLRTI. Thismeans
that, for admitting clinicians, a careful reviewof thepatient's history and
identiﬁcation of salient epidemiological risk factors (e.g., housing, occu-
pation, known local outbreaks) remain of paramount importance.
Laboratory diagnosis of adenoviral infection can be challenging.
The clinical utility of viral cultures for identiﬁcation of adenovirus
is limited by time to positivity (≤7 days) and antigen testing has
low sensitivity and speciﬁcity.2 Therefore, adenovirus identiﬁcation
is best achieved using PCR. However, a positive PCR result does not
equate to aetiology and must be evaluated in the clinical context.2
Both of our patients had high adenoviral loads and viraemia, which,
in the context of conﬁrmed adenoviral sLRTI in immunocompetentenovirus Type 7 causing severe lower respiratory tract infection in
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Table 1
Clinical features, investigations, treatment and outcome of two cases of adenovirus sLRTI.
Case Comorbidities Presentation Initial blood
results
Radiological ﬁndings Virology results Adenovirus treatment
given & AEs
Outcome
Case 1:
35
year
old
female
Asthmatic,
obese, mental
illness
4 day history of URTI
and LRTI symptoms
Presented in peak
inﬂuenza season
Lymphopenia,
mildly raised
CRP
No initial renal
dysfunctiona
CXR: bilateral
consolidation, worsening
during admission (Fig. 1)
Throat swab:
adenovirus PCR
positive
BAL: adenovirus PCR
positive at 5.8 × 108
gEq/ml
EDTA plasma:
adenovirus PCR
positive at 9.5 × 106
gEq/mlb
Adenovirus species B
type 7 by genomic
sequencing
Cidofovir – renal
impairment requiring
RRT
Consideration for
ECMO but not initiated
due to improvement
Decannulated on day 52
and stepped down to ward
level care on day 65
Case 2:
73
year
old
male
Hypertension,
nephrolithiasis
3 day history of
generalised and
gastrointestinal
symptoms
Presented outside of
inﬂuenza season
Lymphopenia,
mildly raised
CRP
No initial renal
dysfunctiona
CT chest: left-sided
pneumonia and bilateral
pleural effusions (Fig. 1)
Throat swab:
adenovirus PCR
positive
BAL: adenovirus PCR
positive at 7.5 × 109
gEq/ml
EDTA plasma:
adenovirus PCR
positive at 2.0 × 106
gEq/mlb
Adenovirus species B
type 7 by genomic
sequencing
Cidofovir – renal
impairment requiring
RRT
IVIG also given
Consideration for
ECMO but not initiated
due to futility.
Died on day 12 due to
multi-organ failure
Abbreviations: BBV=blood borne viruses; LRTI= lower respiratory tract infection;HIV, human immunodeﬁciency virus; CRP=C-reactive protein; CXR= chest radiograph; CT= com-
puted tomography; BAL=bronchoalveolar lavage; RRT= renal replacement therapy; ECMO=extra-corporeal membrane oxygenation; gEq/ml= genome equivalents/millilitre, IVIG=
intravenous immunoglobulin; HDU= high dependency unit (Level 2 Care), URTI = upper respiratory tract infection.
a Other initial blood tests including haemoglobin, platelets, clotting proﬁle, liver function tests, and bone proﬁle were normal.
b Full infection screen included blood cultures, legionella/pneumococcal urinary antigens, urine bacterial culture, blood-borne virus (e.g. HIV, Hepatitis B, and Hepatitis C), serum EDTA
plasma: EBV PCR (positive in Case 1 at 728 copies gEq/ml and positive Case 2 at 908 copies gEq/ml, log 3), CMV PCR negative in Cases 1 and 2, upper respiratory tract bacterial culture and
extended viral PCR panel, sputummicroscopy and bacterial culture and extended viral PCR panel (including from BAL samples), faecal bacterial culture and Clostridium difﬁcile screening,
and resistant organism swabs including VRE and CPE (Case 2 was VRE positive).
3T. Wingﬁeld et al. / Clinical Infection in Practice xxx (xxxx) xxxchildren and adults, are associated with worse prognosis and higher
mortality.12 Our patients' viraemia could also suggest disseminated
adenoviral disease but no relevant samples (e.g. tissue biopsy)
were taken to conﬁrm this.Fig. 1. Radiological ﬁndings
Please cite this article as: T. Wingﬁeld, L. Dearden, P. Calvert, et al., Ad
immunocompetent adults: a comp..., Clinical Infection in Practice, https://To identify adenovirus type in our cases, two PCR assays targeting
different regions of the adenovirus genome were used to amplify PCR
products from BAL samples, two regions of the adenovirus hexon gene
were sequenced using Sanger dideoxy sequencing methods, and thesein Case 1 versus Case 2.
enovirus Type 7 causing severe lower respiratory tract infection in
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4 T. Wingﬁeld et al. / Clinical Infection in Practice xxx (xxxx) xxxwere then compared usingBLAST for similarity to known adenovirus se-
quences in national databases.13–15 Partial hexon gene sequences
(1436 bp) obtained from one PCR assay covering the hypervariable re-
gion were compared with HAdV-B7 reference strains available in
GenBank (this study GenBank accession numbers MN199306,
MN199307). Sequences were aligned using ClustalW embedded in
BioEdit (V 7.0.5.3.), and a maximum likelihood phylogenetic tree was
constructed using the Tamura 3-parameter model in MEGA7 (Fig.
2).16,17 DNA extraction from all samples was done using the
QIAsymphony DSP DNA Kit on the QIAsymphony instrument (QIAGEN
Instruments AG, Hombrechtikon, Switzerland), the adenovirus quanti-
tative PCR method used was the one described by Heim et al.,13 and
run on the LightCycler 480 Instrument (Roche, Basel, Switzerland).
Both of our patients had adenovirus type 7, which was not associ-
ated with any known, local outbreaks, but has been implicated in out-
breaks in the literature: adenovirus types 3 and 7 were isolated from
541/800 previously-healthy individuals with acute respiratory illness
in a military barracks6; and of 198 patients with proven adenovirus
LRTI in Oregon,5 one third had adenovirus type 7, which was also asso-
ciated with higher morbidity than non-type 7. Partial hexon gene se-
quences (hypervariable region) from the two cases described here
showed 99.7% similarity to each other. Sequence from Case 2 clustered
together with recent HAdV-B7d sequences from China and the Oregon
LRTI patients. Sequence from Case 1 did not form part of this cluster
(Fig. 2). Although sequencing of the hexon hypervariable region is
strongly correlated with virus serotype, as these were only partial
hexon gene sequences, whole genome sequencing would be required
to provide full genomic detail, to determine whether recombination
had occurred and deﬁnitively deﬁne the genotype. It has been postu-
lated that military recruits are at increased risk of adenovirus infection
due to crowding and also the physical and psychological stress associ-
ated with their training.6 In addition, it has been suggested that obesityFig. 2. Evolutionary relationship of Human Adenovirus type B7 (HAdV-B7) partial hexon gene
maximum likelihood phylogenetic tree was constructed using the Tamura 3-parameter model
The tree is drawn to scale, with branch lengths measured in the number of substitutions per sit
identiﬁed by GenBank accession number, geographic location, year of sample collection, and
highlighted: Human Adenovirus (HAdV) strains Human\England\05.1\2018\B7 (MN199306) a
Please cite this article as: T. Wingﬁeld, L. Dearden, P. Calvert, et al., Ad
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viduals although the exact mechanism behind this remains unclear.18
Therefore, adenovirus type 7 may have been the cause of the severity
of illness seen in our patients but equally it could have related to obesity,
chronic lung disease, smoking, and social risk factors including unstable
housing as external stressors (Case 1) and advanced age and comorbid-
ities coupledwith extensive physical exertion shortly prior to admission
during an extended hike (Case 2).
Randomised-controlled trial evidence for antiviral treatments in ad-
enovirus infection is lacking19 with the mainstay of care being support-
ive, including ECMO and renal replacement where necessary.20
Cidofovir has been shown to reduce adenoviral loads in a case series
of 7 patients (all of whom survived) but its use, as in our patients, is lim-
ited by nephrotoxicity.21 Brincidofovir, a lipid ester of cidofovir, is an
emerging alternative adenovirus therapy that does not cause nephro-
toxicity and is currently undergoing randomised controlled
evaluation.22 There is no evidence for IVIG in adenovirus infections
but it was given to Case 2 due to biologically-plausible beneﬁt of provid-
ing antibodies directed against the virus.
Conclusions
Severe lower respiratory tract infection with adenovirus, especially
type 7, can cause signiﬁcantmorbidity andmortality. Clinical and radio-
logical features are similar to other infective causes of LRTI, pneumonia
and ARDS (including severe inﬂuenza) but, as in Case 2 and similar to
recent inﬂuenza epidemics, presenting symptoms can be non-speciﬁc.
Positive adenovirus PCR can support a diagnosis in patients with a clin-
ically compatible syndrome and no other identiﬁed aetiology, and
higher viral loads are associated with worse prognosis. Although treat-
ment is predominantly supportive, early use of cidofovir may improve
outcomes. These two rare cases highlight that adenovirus sLRTI shouldsequences including sequences obtained from two cases of adenovirus sLRTI. Legend: The
in MEGA7 and is mid-point rooted.16,17 Bootstrap values (N50%) are shown for key nodes.
e. Scale bar indicates estimated number of nucleotide substitutions per site. Sequences are
virus genome type identiﬁed. Sequences obtained from cases described in this study are
nd Human\England\21.1\2018\B7 (MN199307).
enovirus Type 7 causing severe lower respiratory tract infection in
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5T. Wingﬁeld et al. / Clinical Infection in Practice xxx (xxxx) xxxbe considered in the differential diagnoses of immunocompetent adults
presenting with sLRTI, pneumonia, and/or ARDS.Acknowledgements
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